KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $360.4 million.

  • Cme's Shares Outstanding (Diluted Average) rose 12.03% to $360.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.4 million, marking a year-over-year increase of 12.03%. This contributed to the annual value of $359.9 million for FY2024, which is 12.35% up from last year.
  • According to the latest figures from Q3 2025, Cme's Shares Outstanding (Diluted Average) is $360.4 million, which was up 12.03% from $360.4 million recorded in Q2 2025.
  • In the past 5 years, Cme's Shares Outstanding (Diluted Average) registered a high of $360.4 million during Q3 2025, and its lowest value of $358.8 million during Q1 2021.
  • In the last 5 years, Cme's Shares Outstanding (Diluted Average) had a median value of $359.4 million in 2023 and averaged $359.5 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first increased by 3.7% in 2023, then rose by 14.47% in 2024.
  • Cme's Shares Outstanding (Diluted Average) (Quarter) stood at $358.9 million in 2021, then grew by 0.07% to $359.2 million in 2022, then rose by 0.09% to $359.5 million in 2023, then grew by 0.12% to $359.9 million in 2024, then grew by 0.13% to $360.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $360.4 million in Q3 2025, compared to $360.4 million in Q2 2025 and $360.2 million in Q1 2025.